Daily Activity and Gait Analysis After Viscosupplement Injection Among Hip Osteoarthritis Patients

Laval University

Status and phase

Completed

Phase 4

Conditions

Hip Osteoarthritis

Treatments

Drug: Bupivacaine

Drug: Hyaluronan

Study type

Interventional

Funder types

Other

Identifiers

NCT02086474

INF-2014

Details and patient eligibility

About

The objective of this study is to assess the changes in daily physical activity and gait pattern, following a viscosupplement injection among a population who is suffering from hip osteoarthritis. A kinetic and kinematic gait analysis, an Actigraph activity monitor, a functional Timed-Stair-Test and two questionnaires (Medical Outcome Study Short-Form36 (MOS-SF36), Hip disability and Osteoarthritis Outcome Score (HOOS)) about how the pathology affects the quality of life, will be use.

Enrollment

38 patients

Sex

All

Ages

45 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

From 45 years old to 65 years old
Clinically symptomatic moderate or severe hip osteoarthritis (Tönnis Grade II to III)
Capacity to keep steady upright position and walking during 15 minutes
Body mass index < 40kg/m2

Exclusion criteria

Bilateral hip osteoarthritis
No broken hip or leg during the last 12 months
Bone necrosis
Rheumatoid arthritis, articular chondrocalcinosis, metabolic bone disease, psoriasis, gout, active infection
Per os corticosteroid treatment
Corticosteroid injection < 3 months
Viscosupplement injection < 6 months
Hypersensitivity to hyaluronic acid products
Planed surgery during study duration
Physical or mental disability to fill in questionnaires and/or to participate to follow-up